Analystreport

Bellus Health Inc. (NYSE: BLU) had its price target lowered by analysts at HC Wainwright from $28.00 to $10.00. They now have a "buy" rating on the stock.

BELLUS Health Inc. - Common Shares  (BLU) 
Last bellus health inc. - common shares earnings: 11/14 07:00 am Check Earnings Report